Shanghai RAAS Blood Products Co., Ltd. (002252) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai RAAS Blood Products Co., Ltd.

Why is Shanghai RAAS Blood Products Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 24.05% and Operating profit at 12.65% over the last 5 years

Negative results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY -43.55 MM
NET PROFIT(9M) At CNY 1,470.74 MM has Grown at -19.97%
ROCE(HY) Lowest at 5.73%

Below par performance in long term as well as near term

Along with generating -16.79% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai RAAS Blood Products Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shanghai RAAS Blood Products Co., Ltd.

-15.63%

-1.70

13.29%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

24.05%

EBIT Growth (5y)

12.65%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.25

Tax Ratio

18.73%

Dividend Payout Ratio

21.19%

Pledged Shares

Institutional Holding

ROCE (avg)

7.22%

ROE (avg)

6.49%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.37

EV to EBIT

23.38

EV to EBITDA

21.13

EV to Capital Employed

1.36

EV to Sales

5.69

PEG Ratio

3.01

Dividend Yield

1.06%

ROCE (Latest)

5.83%

ROE (Latest)

6.12%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

DIVIDEND PAYOUT RATIO(Y)

Highest at 22.84%

DIVIDEND PER SHARE(HY)

Highest at CNY 3.68

NET SALES(Q)

Highest at CNY 2,138.86 MM

-27What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY -43.55 MM

NET PROFIT(9M)

At CNY 1,470.74 MM has Grown at -19.97%

ROCE(HY)

Lowest at 5.73%

INTEREST COVERAGE RATIO(Q)

Lowest at 2,502.39

RAW MATERIAL COST(Y)

Grown by 10.39% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 2.77 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.17 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.68 times

INTEREST(Q)

Highest at CNY 17.35 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 20.3 %

Here's what is working for Shanghai RAAS Blood Products Co., Ltd.

Net Sales

Highest at CNY 2,138.86 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Dividend per share

Highest at CNY 3.68

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio

Highest at 22.84%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for Shanghai RAAS Blood Products Co., Ltd.

Operating Cash Flow

Lowest at CNY -43.55 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 17.35 MM has Grown at 201.58%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 2,502.39

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Profit

At CNY 1,470.74 MM has Grown at -19.97%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Interest

Highest at CNY 17.35 MM

in the last five periods and Increased by 201.58% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit Margin

Lowest at 20.3 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at 2.77 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 1.17 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 3.68 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 10.39% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales